MTAP and breast cancer: To specifically inhibit the growth of breast cancers with low MTAP expression, Zhang and colleagues demonstrated the effect of difluoromethylornithine (DFMO) in inhibiting ODC and further reducing tumor migration, invasion, and angiogenesis in MTAP-knockdown (MTAP-KD) breast cancer cells [61].